Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
The summary for the Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21): NIOSH supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty with respect to individuals, including enrolled WTC responders and certified-eligible WTC survivors, receiving monitoring or treatment under subtitle B, of the James Zadroga 9/11 health and Compensation Act. NIOSH seeks to achieve a suitable mix of projects that help advance treatment effectiveness and the understanding of health impacts related to the September 2001 terrorist attacks.This FOA invites applications from researchers who are at the early stage of their independent careers or those who have not had substantial prior NIH/CDC funding. Importantly, applicants are expected to propose research approaches for which there are minimal or no preliminary data.
Federal Grant Title: | Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-OH-21-004 |
Type of Funding: | Grant |
CFDA Numbers: | 93.262 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | December 8th, 2020 |
Original Application Deadline: | December 8th, 2020 |
Posted Date: | August 14th, 2020 |
Creation Date: | August 14th, 2020 |
Archive Date: | January 7th, 2021 |
Total Program Funding: | $3,000,000 |
Maximum Federal Grant Award: | $275,000 |
Minimum Federal Grant Award: | $175,000 |
Expected Number of Awards: | 8 |
Cost Sharing or Matching: | No |
Last Updated: | August 14th, 2020 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-OH-21-004.html
- Grant Announcement Contact
- James Yiin
[email protected]
[email protected] - Similar Government Grants
- • World Trade Center Health Program Mentored Research Scientist Career Development Award (K0...
- • Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade...
- • Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Appli...
- • National Center for Construction Safety and Health Research and Translation (U54)
- • NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
- • Career Development Grants in Occupational Safety and Health Research (K01)
- • World Trade Center Health Consortium
- • Mining Safety and Health Training and Translation Center
- More Grants from the Centers for Disease Control and Prevention ERA
- • Collaborative research on influenza and other respiratory pathogens in South Africa
- • Advancing Public Health Research in Bangladesh
- • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...
- • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...